Opinion: DMD Gene Therapy’s Inflection Point and the Case for Small Molecules
Originally published on BioSpace iStock, alexkich As AAV9 and CRISPR programs navigate safety, delivery and scalability hurdles, small molecules offer a […]
Originally published on BioSpace iStock, alexkich As AAV9 and CRISPR programs navigate safety, delivery and scalability hurdles, small molecules offer a […]
Funding to speed development of next‑generation treatments for Duchenne muscular dystrophy. RENO, NV, UNITED STATES, August 22,2025 /EINPresswire.com/ —Sarcomatrix Therapeutics,